PerkinElmer to Host Virtual Investor and Analyst Day

WALTHAM, Mass.–(BUSINESS WIRE)–May 4, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a virtual Investor and Analyst Day on Thursday, June 24, 2021 from 8:30 a.m. to 12:00 p.m. ET. The virtual format will feature presentations by members of PerkinElmer’s senior... Read more

PerkinElmer Announces Financial Results for the First Quarter of 2021

Revenue of $1.308 billion; 100% reported growth; 92% organic growth GAAP EPS from continuing operations of $3.37; Adjusted EPS of $3.72 Initiates Second Quarter and Raises Full-Year Revenue and Earnings Guidance WALTHAM, Mass.–(BUSINESS WIRE)–May 4, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for... Read more

Fully Automated Thermo Scientific Nexsa G2 Accelerates Surface Material Analysis with XPS

Fully Automated Thermo Scientific Nexsa G2 Accelerates Surface Material Analysis with XPS HILLSBORO, Ore., May 3, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced the Thermo Scientific Nexsa G2 surface analysis system — a fully automated x-ray photoelectron spectrometer (XPS) designed to increase productivity and innovation for academic and industrial... Read more

Thermo Scientific E-CFEG Enables Accelerated Cryo-EM Discovery with High Resolution Data

Thermo Scientific E-CFEG Enables Accelerated Cryo-EM Discovery with High Resolution Data A value-add for Krios Cryo-TEM, this new electron source works as part of four major components to push contrast, resolution, and speed to industry-leading levels HILLSBORO, Ore., April 30, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today launched the Thermo... Read more

Thermo Fisher Scientific Reports First Quarter 2021 Results

WALTHAM, Mass., April 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021. First Quarter 2021 Highlights First quarter revenue increased 59% to $9.91 billion. First quarter GAAP diluted earnings per share (EPS) increased 198% to $5.88.... Read more

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society WALTHAM, Mass. (April 28, 2021) — Thermo Fisher Scientific Inc. has made a donation to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval... Read more

Danaher Announces Renowned Scientists To Join New Scientific Advisory Board

DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT WASHINGTON, April 26, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”), the global science and technology company, announced today the formation of a Scientific Advisory Board (“Board”) to support its innovation and investment strategy. The Board will help the company protect and grow existing... Read more

Danaher Reports First Quarter 2021 Results

WASHINGTON, April 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2021.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended April 2, 2021, net earnings were $1.7 billion, or $2.29 per diluted common share which represents a 182.5% year-over-year... Read more